Tizanidine Tablet
Product Images NDC 68788-7781

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 68788-7781). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine Hydrochloride Tablet 4mg (Container1)

Tizanidine Hydrochloride Tablet 4 mg label for oral tablets by Preferred Pharmaceuticals, Inc. The label states it is generic for Zanaflex and each tablet contains 4.576 mg tizanidine HCl equivalent to 4 mg tizanidine base. Manufacturer is Dr Reddy's Laboratories Limited. The label includes storage instructions, a barcode, a warning about drowsiness, and directions for use in English and Spanish.*

FDA Label Image

Fig1 (Fig1)

A pharmacokinetic curve showing plasma tizanidine concentration (ng/mL) over 26 hours from dosing. The graph compares four conditions: 2 x 4 mg Tizanidine tablets with food, tablets without food, capsules with food, and capsules without food. Concentration peaks occur within the first few hours and decline thereafter.*

FDA Label Image

Fig2 (Fig2)

A line graph showing improvement in Ashworth Score over time (hours post-dose) for 16 mg tizanidine, 8 mg tizanidine, and placebo groups. The y-axis represents improvement in Ashworth Score, and the x-axis represents hours post-dose, with error bars indicating variability at each time point.*

FDA Label Image

Fig3 (Fig3)

A line graph comparing improvement in Ashworth Score over time between Tizanidine (mean dose 28.8 mg) and placebo groups. The x-axis represents time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). The y-axis shows improvement scores ranging from -6 to 2, with Tizanidine consistently showing greater improvement than placebo at all time points.*

FDA Label Image

Structure (Structure)

Chemical structure of Tizanidine hydrochloride, the active ingredient shown in this diagram, depicting its molecular composition and arrangement.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.